Old CIC Events
![Poster presentation of the master's degree in Biology and Clinic of Cancer](/media/2273/alumnos-master-23_tv.jpg?width=350&height=200&mode=crop)
Poster presentation of the master's degree in Biology and Clinic of Cancer
Master's students —
![N6-ADENOSINE METHYLTRANSFERASE COMPLEX REGULATOR ZC3H13 DELETION AS MALIGNANT PROGNOSIS FACTOR IN PROSTATE CANCER](/media/2268/oscar.jpg?width=350&height=200&mode=crop)
N6-ADENOSINE METHYLTRANSFERASE COMPLEX REGULATOR ZC3H13 DELETION AS MALIGNANT PROGNOSIS FACTOR IN PROSTATE CANCER
Óscar Monteagudo — Epitranscriptomic and Cancer Lab, Centro de Investigación del Cáncer (CIC)
![Specific killing of BRCA1-deficient cancer cells by depletion of EXO1](/media/2257/haico-van-attikum_16-marzo.jpg?width=350&height=200&mode=crop)
Specific killing of BRCA1-deficient cancer cells by depletion of EXO1
Haico van Attikum — Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands
![RAS-p110a signalling controls macrophage-derived inflammatory response by favouring transendothelial migration and phagocytic capacity.](/media/2258/alejandro-rosell.jpg?width=350&height=200&mode=crop)
RAS-p110a signalling controls macrophage-derived inflammatory response by favouring transendothelial migration and phagocytic capacity.
Alejandro Rosell Jiménez — Centro de Investigación del Cáncer (CSIC-USAL), Salamanca
![Connecting myeloid cell metabolism and function](/media/2228/david_marzo.jpg?width=350&height=200&mode=crop)
Connecting myeloid cell metabolism and function
David Sancho Madrid — Centro Nacional de Investigaciones Cardiovasculares de Madrid
![AHR adjusts senescence and stemness: impact in tissue regeneration and tumor progression](/media/2182/pedro-m-fernandez-salguero.jpg?width=350&height=200&mode=crop)
AHR adjusts senescence and stemness: impact in tissue regeneration and tumor progression
Pedro M. Fernández Salguero — Universidad de Extremadura, Badajoz.
![ctDNA in cancer care](/media/2230/elza-de-bruin_web.jpg?width=350&height=200&mode=crop)
ctDNA in cancer care
Elza de Bruin — Director Translational Medicine, AstraZeneca, Cambridge, UK
![Metabolic Reprogramming in Cancer Progression: Making the difference](/media/2222/patricia-altea-manzano_web.jpg?width=350&height=200&mode=crop)
Metabolic Reprogramming in Cancer Progression: Making the difference
Patricia Altea Manzano — Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Belgium
![Spatial synthetic lethality- a new approach to treat B cell lymphoma (?)](/media/2190/ir.jpg?width=350&height=200&mode=crop)
Spatial synthetic lethality- a new approach to treat B cell lymphoma (?)
Ingo Ringshausen — University of Cambridge, Wellcome–MRC Cambridge Stem Cell Institute
![Self-organization of MAPK Signaling Dynamics in the Epithelium](/media/2186/olivier_pertz_web.jpg?width=350&height=200&mode=crop)
Self-organization of MAPK Signaling Dynamics in the Epithelium
Olivier Pertz — Institute of Cell Biology, University of Bern (Swizerland)
![Cell-of-origin as a route to understand the onset of aggressive prostate tumours](/media/2188/esther-baena-web.jpg?width=350&height=200&mode=crop)
Cell-of-origin as a route to understand the onset of aggressive prostate tumours
Esther Baena — Cancer Research UK Manchester Institute, University of Manchester